Jon Jones’ future may be revealed soon, and his team expects some good news.
The former UFC light heavyweight champion met with the U.S. Anti-Doping Agency for an arbitration hearing following his positive drug test from June 2016. Jones and his team are confident they have evidence that would warrant a reduction from the yearlong suspension he would otherwise face.
“I think that the evidence all came in and we’re happy with, sort of, how the case went. And now we’re just going to wait for the decision. It’s out of our hands, now,” Jones’ lawyer Howard Jacobs told MMA Fighting.
“I don’t want to get into the details, but there was a lot of evidence that was heard and a lot of argument,” Jacobs said. “Think of it like a trial. It’s basically like the same. It just takes more time than you would think.”
Jones tested positive for multiple estrogen blockers in the lead-up to his UFC 200 fight back in July. Expected to challenge Daniel Cormier in a rematch for the light heavyweight crown, Jones was pulled from the contest just three days prior. His team, however, recently indicated that they were able to trace the banned substances to tainted supplements Jones was taking prior to the contest, which has historically allowed fighters like Yoel Romero and Tim Means to receive shortened suspensions by USADA.
Unlike Romero or Means, “Bones” wasn’t given a settlement option that he or his team were comfortable accepting, prompting him to become the first fighter in UFC history to enter arbitration with USADA.